16 results
P
Monte Carlo simulations
I/C
meta-analytical approaches, continuity correction methods, fixed effects, random effects
O
postoperative risk results, MSE values, effect of treatment, variance values between studies
P
Rodrigues RP, Vidigal MT, Vieira WA, Nascimento GG, Sabino-Silva R
I/C
hemodialysis
O
salivary changes in chronic kidney disease
P
Lemos CA, Verri FR, de Oliveira Neto OB, Cruz RS, Gomes JML, da Silva Casado BG
I/C
high insertion torque, no intervention
O
dental implant success
P
South Africa, India, Turkey, Pakistan, Canada, Hong Kong, China
I/C
α-HCH, β-HCH, γ-HCH, ∑-HCH, Heptachlor, Aldrin, p,p'-DDE, p,p'-DDT, ∑-DDT, ∑-OCP, Surface water, Drinking water, Seawater, Groundwater
O
Concentration and prevalence of POPs, Carcinogenic risk, Non-carcinogenic risk
P
children and adolescents with Down Syndrome
I/C
Caries experience
O
caries prevalence
P
ONCOLOGY
I/C
DRUG, COMBINATION, PREVIOUSLY
O
SAFETY, DOSE-TOXICITY RELATIONSHIP
P
Framingham Heart Study, Osteoporosis in Men Study
I/C
gut microbiome, human gut microbiome and skeletal health
O
association between the human gut microbiome and high resolution peripheral quantitative computed tomography (HR-pQCT) scans of the radius and tibia
P
functional constipation (FC)
I/C
acupuncture, sham acupuncture
O
complete spontaneous bowel movement (CSBM), spontaneous bowel movement, Bristol Stool Form Scale (BSFS), responder rate, safety evaluation (SE)
P
early-stage cervical cancer
I/C
preoperative conization, radical hysterectomy with preoperative conization (CO) vs radical hysterectomy without preoperative conization (NCO)
O
disease-free survival outcomes
P
sheep, cattle
I/C
gamithromycin, lincomycin, oxytetracycline, erythromycin, amoxicillin, enrofloxacin, gamithromycin vs. amoxicillin, gamithromycin vs. enrofloxacin, lincomycin vs. oxytetracycline, erythromycin vs. oxytetracycline
O
curing rate